Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Return of the Coronavirus: 2019-nCoV.
Gralinski LE, Menachery VD. Gralinski LE, et al. Viruses. 2020 Jan 24;12(2):135. doi: 10.3390/v12020135. Viruses. 2020. PMID: 31991541 Free PMC article.
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2.
Walls AC, Fiala B, Schäfer A, Wrenn S, Pham MN, Murphy M, Tse LV, Shehata L, O'Connor MA, Chen C, Navarro MJ, Miranda MC, Pettie D, Ravichandran R, Kraft JC, Ogohara C, Palser A, Chalk S, Lee EC, Kepl E, Chow CM, Sydeman C, Hodge EA, Brown B, Fuller JT, Dinnon KH 3rd, Gralinski LE, Leist SR, Gully KL, Lewis TB, Guttman M, Chu HY, Lee KK, Fuller DH, Baric RS, Kellam P, Carter L, Pepper M, Sheahan TP, Veesler D, King NP. Walls AC, et al. Among authors: gralinski le. bioRxiv. 2020 Aug 12:2020.08.11.247395. doi: 10.1101/2020.08.11.247395. Preprint. bioRxiv. 2020. PMID: 32817941 Free PMC article. Updated.
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures.
Dinnon KH, Leist SR, Schäfer A, Edwards CE, Martinez DR, Montgomery SA, West A, Yount BL, Hou YJ, Adams LE, Gully KL, Brown AJ, Huang E, Bryant MD, Choong IC, Glenn JS, Gralinski LE, Sheahan TP, Baric RS. Dinnon KH, et al. Among authors: gralinski le. bioRxiv. 2020 May 7:2020.05.06.081497. doi: 10.1101/2020.05.06.081497. Preprint. bioRxiv. 2020. PMID: 32511406 Free PMC article. Updated.
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals.
Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RE, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Williamson LE, Chen EC, Jones T, Day S, Myers L, Hassan AO, Kafai NM, Winkler ES, Fox JM, Steinhardt JJ, Ren K, Loo YM, Kallewaard NL, Martinez DR, Schäfer A, Gralinski LE, Baric RS, Thackray LB, Diamond MS, Carnahan RH, Crowe JE. Zost SJ, et al. Among authors: gralinski le. bioRxiv. 2020 May 22:2020.05.22.111005. doi: 10.1101/2020.05.22.111005. Preprint. bioRxiv. 2020. PMID: 32511409 Free PMC article. Updated.
Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice.
Bottomly D, Ferris MT, Aicher LD, Rosenzweig E, Whitmore A, Aylor DL, Haagmans BL, Gralinski LE, Bradel-Tretheway BG, Bryan JT, Threadgill DW, de Villena FP, Baric RS, Katze MG, Heise M, McWeeney SK. Bottomly D, et al. Among authors: gralinski le. G3 (Bethesda). 2012 Feb;2(2):213-21. doi: 10.1534/g3.111.001800. Epub 2012 Feb 1. G3 (Bethesda). 2012. PMID: 22384400 Free PMC article.
SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo.
Hou YJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH 3rd, Leist SR, Schäfer A, Nakajima N, Takahashi K, Lee RE, Mascenik TM, Edwards CE, Tse LV, Boucher RC, Randell SH, Suzuki T, Gralinski LE, Kawaoka Y, Baric RS. Hou YJ, et al. Among authors: gralinski le. bioRxiv. 2020 Sep 29:2020.09.28.317685. doi: 10.1101/2020.09.28.317685. Preprint. bioRxiv. 2020. PMID: 33024969 Free PMC article. Updated.
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801.
Wahl A, Gralinski L, Johnson C, Yao W, Kovarova M, Dinnon K, Liu H, Madden V, Krzystek H, De C, White K, Schäfer A, Zaman T, Leist S, Grant P, Gully K, Askin F, Browne E, Jones C, Pickles R, Baric R, Garcia JV. Wahl A, et al. Res Sq. 2020 Sep 24:rs.3.rs-80404. doi: 10.21203/rs.3.rs-80404/v1. Preprint. Res Sq. 2020. PMID: 32995766 Free PMC article.
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page